Pure H2O Bio-Technologies, Inc. Announces New Testing Results for Tetrasilver Tetraoxide as a Disinfectant for Major Microbial D
November 21 2006 - 12:45PM
Business Wire
Pure H2O Bio-Technologies, Inc. (Pink Sheets:PRHB) announced today
the results from three successful studies focused on potable water
disinfection treatment for two major microbial threats to human
health. The microorganisms, Escherichia coli (bacterium) and
Cryptosporidium parvum (protozoan parasite of humans), were
responsible for 9,877 and 7,212 human cases, respectively, during
2005 according to a March 2006 American Waterworks Association
review article by P. Rochelle and J. Clancy. Testing conducted for
Pure H2O Bio-Technologies, Inc., by Clancy Environmental
Consultants, Inc. showed that activated tetrasilver tetraoxide
(TTO) was effective as a disinfectant for both organisms. TTO is a
unique divalent silver compound, which is produced in a crystalline
form, with disinfectant properties superior to the common forms of
silver. Joseph P. Doxey, president of Pure H2O Bio-Technologies,
Inc. said: "The results show that the company can use this
disinfectant as an alternative to those which are in current
municipal and commercial use for drinking water treatment.
Moreover, these studies on tetrasilver tetraoxide (patent pending)
reported on July 1, 2005, Sept. 8, 2006 and October 25, 2006,
respectively, are significant because Cryptosporidium oocysts are
resistant to halogens such as chlorine and this pathogen has been
known to escape state-of-the-art municipal water treatment systems
and result in many human health outbreaks. E. coli although more
easily disinfected, also has special significance as a waterborne
and foodborne pathogen involved in recent outbreaks." Reports from
the Pure H2O Bio-Technologies studies of July 1, 2005 and October
25, 2006 showed that low concentrations of TTO, activated by two
different oxidizing agents caused significant reductions in high
concentrations of Cryptosporidium oocysts (highly resistant form of
this waterborne parasite). The Sept. 8, 2006 study showed that
activated/oxidized TTO caused more than a five-log10 reduction of
E. coli (killed more than 100,000 bacteria) in 2 and 5 min. Thus,
TTO can be incorporated into the contained drinking water
disinfection system developed by Pure H20 Bio-Technologies and
which will be submitted to the EPA verification conducted through
NSF. The Company PHBT is a publicly held company specializing in
the manufacturing, design and sale of its unique residential,
commercial and hospital point-of-use potable water disinfection
systems. These systems are specifically designed to work
effectively against water-borne pathogens and remove heavy metals
and objectionable biomass. Note: The foregoing press release
contains forward-looking statements that can be identified by such
terminology as "expects," "potential," "suggests," "may,"
"intends," or similar expressions. Such forward-looking statements
involve known and unknown risks, uncertainties, and other factors
that may cause the actual results to be materially different from
any future results, performance or achievements expressed or
implied by such statements. In particular, management's
expectations regarding future research, development, and/or
commercial results could be affected by, among other things,
uncertainties relating to the availability of future financing;
unexpected regulatory delays or government regulation generally;
the company's ability to obtain or maintain patent and other
proprietary intellectual property protection; and completion in
general. Forward-looking statements speak only as to the date they
were made. The company does not undertake to update forward-looking
statements to reflect circumstances or events that occur after the
date the forward-looking statements are made. Pure H2O
Bio-Technologies, Inc. (Pink Sheets:PRHB) announced today the
results from three successful studies focused on potable water
disinfection treatment for two major microbial threats to human
health. The microorganisms, Escherichia coli (bacterium) and
Cryptosporidium parvum (protozoan parasite of humans), were
responsible for 9,877 and 7,212 human cases, respectively, during
2005 according to a March 2006 American Waterworks Association
review article by P. Rochelle and J. Clancy. Testing conducted for
Pure H2O Bio-Technologies, Inc., by Clancy Environmental
Consultants, Inc. showed that activated tetrasilver tetraoxide
(TTO) was effective as a disinfectant for both organisms. TTO is a
unique divalent silver compound, which is produced in a crystalline
form, with disinfectant properties superior to the common forms of
silver. Joseph P. Doxey, president of Pure H2O Bio-Technologies,
Inc. said: "The results show that the company can use this
disinfectant as an alternative to those which are in current
municipal and commercial use for drinking water treatment.
Moreover, these studies on tetrasilver tetraoxide (patent pending)
reported on July 1, 2005, Sept. 8, 2006 and October 25, 2006,
respectively, are significant because Cryptosporidium oocysts are
resistant to halogens such as chlorine and this pathogen has been
known to escape state-of-the-art municipal water treatment systems
and result in many human health outbreaks. E. coli although more
easily disinfected, also has special significance as a waterborne
and foodborne pathogen involved in recent outbreaks." Reports from
the Pure H2O Bio-Technologies studies of July 1, 2005 and October
25, 2006 showed that low concentrations of TTO, activated by two
different oxidizing agents caused significant reductions in high
concentrations of Cryptosporidium oocysts (highly resistant form of
this waterborne parasite). The Sept. 8, 2006 study showed that
activated/oxidized TTO caused more than a five-log10 reduction of
E. coli (killed more than 100,000 bacteria) in 2 and 5 min. Thus,
TTO can be incorporated into the contained drinking water
disinfection system developed by Pure H20 Bio-Technologies and
which will be submitted to the EPA verification conducted through
NSF. The Company PHBT is a publicly held company specializing in
the manufacturing, design and sale of its unique residential,
commercial and hospital point-of-use potable water disinfection
systems. These systems are specifically designed to work
effectively against water-borne pathogens and remove heavy metals
and objectionable biomass. Note: The foregoing press release
contains forward-looking statements that can be identified by such
terminology as "expects," "potential," "suggests," "may,"
"intends," or similar expressions. Such forward-looking statements
involve known and unknown risks, uncertainties, and other factors
that may cause the actual results to be materially different from
any future results, performance or achievements expressed or
implied by such statements. In particular, management's
expectations regarding future research, development, and/or
commercial results could be affected by, among other things,
uncertainties relating to the availability of future financing;
unexpected regulatory delays or government regulation generally;
the company's ability to obtain or maintain patent and other
proprietary intellectual property protection; and completion in
general. Forward-looking statements speak only as to the date they
were made. The company does not undertake to update forward-looking
statements to reflect circumstances or events that occur after the
date the forward-looking statements are made.
Pure H2O Bio Technologies (CE) (USOTC:PRHB)
Historical Stock Chart
From Jun 2024 to Jul 2024
Pure H2O Bio Technologies (CE) (USOTC:PRHB)
Historical Stock Chart
From Jul 2023 to Jul 2024